Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.25
Bid: 18.00
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 0.50 (2.778%)
Open: 18.25
High: 18.25
Low: 18.25
Prev. Close: 18.25
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: SourceBio Tips Jump In Virus Testing Demand

Wed, 25th Nov 2020 18:00

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

SourceBio International PLC - laboratory services and products firm - Says provides over 330,000 Covid-19 tests to UK Department of Health & Social Care. Continuing to build capacity for Covid-19 testing services and expects more demand in 2021. Expects annual revenue of GBP50 million, more than double GBP21.2 million in 2019. Forecasts earnings before interest, tax, depreciation and amortisation to surge to GBP14.0 million from GBP3.0 million. Renews testing services pact with Spire Healthcare Ltd.

----------

Nanoco Group PLC - Manchester-based quantum dots developer - Secures grant funding from UK innovation agency Innovate UK. Grant will go towards life sciences project to develop a quantum dot testing kit for rapid visual detection of Covid-19. "The project will cost just under GBP1.0 million to which the Innovate grant contributes 80% with the balance funded by Nanoco," company explains.

----------

Sensyne Health PLC - clinical artificial intelligence company - Signs five-year non-exclusive research agreement with Hampshire Hospitals NHS Foundation Trust which will probe the ethical application of artificial intelligence research to improve patient care and improve development of new medicines. Says trust will receive 1.1% Sensyne stake and Hampshire hospitals to receive GBP250,000 annual Sensyne invest over five-year term of research pact.

----------

Destiny Pharma PLC - clinical stage biotechnology company based in Brighton - Raises GBP870,000 from ipen offer, taking total fundraise to GBP10.4 million. "We are very pleased with the results of the fundraising and the support from our existing and new shareholders," CEO Neil Clark says.

----------

OPG Power Ventures PLC - Indian power plant operator - Collects about GBP9.5 million from contractual claims from customers under power purchase agreements. "The collection of these claims has strengthened the group's financial position and liquidity during these uncertain times caused by the Covid-19 pandemic," OPG says.

----------

IronRidge Resources Ltd - Africa-focused minerals explorer - Says additional test work completed at Ewoyaa project to improve lithium recoveries. Says "pleased" to have "refined recoveries and mass yields" without loss of concentrate grade.

----------

AEX Gold Inc - Greenland-focused gold miner - Says results from drilling at Nalunaq gold asset in Greenland support interpretation that Valley Block area is a "high-grade domain" similar to South Block. "We are very encouraged at the prospective nature of the Valley Block following the delivery of further interesting drilling results from this year's drilling campaign," Chief Executive Officer Eldur Olafsson says.

----------

Ncondezi Energy Ltd - operator of coal-fired power project in Mozambique - Raises GBP750,000 from oversubscribed placing of 16.7 million shares at 4.5p each.

----------

Pantheon Resources PLC - oil and gas exploration company focused on the Alaska North Slope - Reports rig contract secured with Nordic Calista Services to drill Talitha #A well. Operations to start in January.

----------

URU Metals Ltd - exploration and development - Raises GBP280,600 through subscription of 122,000 depositary interests at 230p each. "The proceeds of the equity placing will be used by the company for general working capital purposes," URU says.

----------

Xeros Technology Group PLC - Rotherham, South Yorkshire-based laundry and garment technology group - Says Indian license partner, Ramsons Garment Finishing Equipment Ltd receives order for nine denim finishing machines which use Xeros technology. "The order represents the first sales of Xeros' innovative XDrum design which fully automates the use of the group's proprietary XOrbs in garment finishing and laundry processes," Xeros says. "In line with the board's expectations, Xeros will receive a mid to high single digit royalty for these machine sales as well as royalties for the ongoing use of XOrbs."

----------

Gresham House Energy Storage Fund PLC - UK utility-scale battery storage fund - Raises GBP120 million through issue of 114.3 million shares at 105 pence each. Funds to go towards finance energy assets as part of 485 megawatt project pipeline being progressed by its manager.

----------

RDL Realisation PLC - debt instrument investor - Serves notice on alternative investment fund manager, International Fund Management Ltd and notifies UK Financial Conduct Authority it intends to become a self-managed AIFM, saving on external management fees. Changes to come into effect in February. Also says it will convene a general meeting to approve Main Market delisting, which it explains will unlock further cost savings.

----------

TMT Investments PLC - Jersey-headquartered technology companies investor - Enters into loan agreement with Macmillan Trading Co Ltd for USD5.0 million financing which incurs no interest and is repayable any time before December 31, 2021. This will allow TMT to continue making investments while waiting for USD41 million cash from Pipedrive Inc disposal.

----------

GlobalData PLC - market research firm - Says in 10 months ended October 31, revenue, excluding events, rose 5% year-on-year. Adjusted earnings before interest, tax, depreciation and amortisation up 12% during period. Expects flat annual revenue despite Covid-19 hurt.

----------

Argo Blockchain PLC - UK-based cryptocurrency miner - Says share capital reduction comes into effect. Share capital comprises 239.8 million shares.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Dec 2019 16:06

Destiny Pharma Says New Guidelines Prove Lead Product Marketability

Destiny Pharma Says New Guidelines Prove Lead Product Marketability

Read more
2 Dec 2019 15:57

Destiny Pharma Appoints Former Polyphor Medical Chief To Board

Destiny Pharma Appoints Former Polyphor Medical Chief To Board

Read more
16 Oct 2019 14:48

Destiny Pharma pleased with latest XF-73 results at it proceeds with next phase

(Sharecast News) - Clinical stage biotechnology company Destiny Pharma reported on the publication of results from a positive phase 1 clinical study in 60 healthy United States volunteers using a nasal gel formulation of its lead drug, XF-73 (exeporfinium chloride), on Wednesday.

Read more
16 Oct 2019 11:36

Destiny Pharma's XF-73 Associated With Reduced Staphylococcus Aureus

Destiny Pharma's XF-73 Associated With Reduced Staphylococcus Aureus

Read more
23 Sep 2019 16:09

Destiny Pharma Says Non-Executive Joe Eagle Steps Down From Board

Destiny Pharma Says Non-Executive Joe Eagle Steps Down From Board

Read more
23 Sep 2019 12:12

Destiny Pharma Interim Loss Narrows On Smaller Share Option Charge

Destiny Pharma Interim Loss Narrows On Smaller Share Option Charge

Read more
10 Sep 2019 14:16

Destiny Pharma Collaboration With University Of Sheffield Wins Funding

(Alliance News) - Destiny Pharma PLC on Tuesday said it has been awarded a grant along with the University of Sheffield for their research collaboration on drug-resistant infections.Shares

Read more
9 Apr 2019 11:17

Destiny Pharma Annual Loss Doubles On Higher Costs, Confident Outlook

LONDON (Alliance News) - Destiny Pharma PLC on Tuesday reported a significantly widened annual loss as expenses surged in the run-up to the development of its lead candidate.For 2018, the a

Read more
9 Apr 2019 09:32

Destiny Pharma 'well funded' despite wider loss

(Sharecast News) - Destiny Pharma on Tuesday reported a wider annual loss as it increased research and development costs, although the company is "well funded" through to the second half of next year.

Read more
2 Apr 2019 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 3 April AAFull Year ResultsCMC MarketsTrading GroupTrading Year Year 4

Read more
27 Mar 2019 11:53

Destiny Pharma, MedPharm To Develop New XF-Platform Drug Formulations

LONDON (Alliance News) - Destiny Pharma PLC on Wednesday said it has partnered with MedPharm to develop new formulations of its XF-platform compounds.MedPharm is a contract provider of and

Read more
28 Jan 2019 11:46

Destiny Pharma Gets Positive Results From Second Phase Trial Of XF-73

LONDON (Alliance News) - Destiny Pharma PLC on Monday reported positive results in a second phase 1 clinical study examining the anti-irritation features of its XF-73 nasal gel.The study, a

Read more
28 Jan 2019 10:39

Destiny Pharma sees success in latest trial of XF-73 nasal gel

(Sharecast News) - Clinical stage biotechnology company Destiny Pharma announced positive data and the non-irritant classification for its XF-73 nasal gel on Monday.

Read more
25 Jan 2019 10:58

Destiny Pharma leaps on £1.6m grant and UK-China collaboration

(Sharecast News) - Destiny Pharma jumped on Friday after being awarded funding of up to £1.6m from a collaboration established under the UK-China AMR grant fund.

Read more
25 Jan 2019 09:53

Destiny Pharma Gets Funding For Antimicrobial Resistance Research

LONDON (Alliance News) - Destiny Pharma PLC said Friday that it has secured a GBP1.6 million grant for examining novel drugs to prevent, control and eradicate life threatening bacteria or without

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.